CEL SCI CORP
10-Q, EX-27, 2000-08-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CEL SCI CORP, 10-Q, 2000-08-14
Next: IMAGING TECHNOLOGIES CORP/CA, S-2, 2000-08-14



<TABLE> <S> <C>


<ARTICLE>                     5

<CIK>                         0000725363
<NAME>                        Cel-Sci Corporation
<MULTIPLIER>                                   1
<CURRENCY>                                     US

<S>                             <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-1-1999
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         9,483,974
<SECURITIES>                                   3,733,945
<RECEIVABLES>                                  59,940
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               14,188,828
<PP&E>                                         2,160,472
<DEPRECIATION>                                 1,690,740
<TOTAL-ASSETS>                                 15,206,730
<CURRENT-LIABILITIES>                          488,242
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       204,572
<OTHER-SE>                                     14,485,595
<TOTAL-LIABILITY-AND-EQUITY>                   15,206,730
<SALES>                                        0
<TOTAL-REVENUES>                               163,775
<CGS>                                          0
<TOTAL-COSTS>                                  2,328,882
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (2,165,107)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,165,107)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,165,107)
<EPS-BASIC>                                    (0.11)
<EPS-DILUTED>                                  (0.11)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission